|
|
Volumn 25, Issue 9, 2007, Pages 1148-
|
|
Processes to activate phase III clinical trials in a cooperative oncology group: The elephant is monstrous [11]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLINICAL DECISION MAKING;
CONSULTATION;
DRUG INDUSTRY;
GOVERNMENT;
HUMAN;
LETTER;
MEDICAL EDUCATION;
MEDICAL SOCIETY;
PHYSICIAN;
POSTGRADUATE EDUCATION;
PRIORITY JOURNAL;
UNIVERSITY HOSPITAL;
CLINICAL PROTOCOL;
COOPERATION;
LEUKEMIA;
METHODOLOGY;
MULTICENTER STUDY;
NEOPLASM;
NOTE;
ONCOLOGY;
PHASE 3 CLINICAL TRIAL;
PROFESSIONAL STANDARD;
TIME;
CLINICAL PROTOCOLS;
CLINICAL TRIALS DATA MONITORING COMMITTEES;
CLINICAL TRIALS, PHASE III;
COOPERATIVE BEHAVIOR;
ETHICS COMMITTEES, RESEARCH;
HUMANS;
LEUKEMIA;
MEDICAL ONCOLOGY;
MULTICENTER STUDIES;
NEOPLASMS;
RESEARCH DESIGN;
TIME FACTORS;
|
|
EID: 34047213606
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.09.5232 Document Type: Letter |
|
Times cited : (8)
|
|
References (2)
|
